blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3773580

EP3773580 - MONO-(ACID) SALTS OF 6-AMINOISOQUINOLINES AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  15.01.2021
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  05.10.2019
Most recent event   Tooltip26.02.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Aerie Pharmaceuticals, Inc.
550 Hills Drive, Third Floor
Bedminster, NJ 07921 / US
[2021/07]
Inventor(s)01 / DELONG, Mitchell A.
212 Hillcrest Circle
Chapel Hill, NC 27514 / US
02 / STURDIVANT, Jill M.
3930 Crawford Dairy Road
Chapel Hill, NC 27516 / US
03 / LICHOROWIC, Cynthia L.
912 Odyssey Dr.
Durham, NC 27713 / US
04 / LIN, Cheng-Wen
6424 Reserve Pine Drive
Cary, NC 27519 / US
 [2021/22]
Former [2021/07]01 / DELONG, Mitchell A.
212 Hillcrest Circle
Chapel Hill, NC 27514 / US
02 / STURDIVANT, Jill M.
3930 Crawford Dairy Road
Chapel Hill, NC 27516 / US
03 / LICHOROWIC, Cynthia L.
8510 Brittdale Lane, 201
Raleigh, NC 27617 / US
04 / LIN, Cheng-Wen
6424 Reserve Pine Drive
Cary, NC 27519 / US
Representative(s)K&L Gates LLP
Friedrichstraße 110 A
10117 Berlin / DE
[N/P]
Former [2021/07]K&L Gates LLP
Markgrafenstrasse 42
10117 Berlin / DE
Application number, filing date19777599.229.03.2019
[2021/07]
WO2019US24954
Priority number, dateUS201862650687P30.03.2018         Original published format: US 201862650687 P
[2021/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019191654
Date:03.10.2019
Language:EN
[2019/40]
Type: A1 Application with search report 
No.:EP3773580
Date:17.02.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 03.10.2019 takes the place of the publication of the European patent application.
[2021/07]
Search report(s)International search report - published on:US03.10.2019
(Supplementary) European search report - dispatched on:EP20.01.2022
ClassificationIPC:A61K31/47, C07D217/22, A61K9/00
[2022/08]
CPC:
A61P27/02 (EP,CN,IL,KR,US); C07D217/04 (EP,IL,US); C07D217/22 (KR);
C07D217/02 (CN); A61K31/472 (CN,KR); A61K9/0048 (IL,KR,US);
A61K9/0051 (EP); A61P25/28 (CN); A61P27/06 (EP,CN,IL,KR,US);
A61P29/00 (EP,CN,IL,US); A61P3/10 (CN); A61P9/12 (CN);
C07C309/25 (CN); C07C309/29 (CN); C07C309/30 (CN,IL,US);
C07C309/32 (CN); C07C309/39 (CN); C07B2200/07 (CN);
C07B2200/13 (IL,US) (-)
Former IPC [2021/07]A61K31/47, C07D217/22
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/07]
TitleGerman:MONO-( SÄURE)SALZE VON 6-AMINOISOCHINOLINEN UND DEREN VERWENDUNGEN[2021/07]
English:MONO-(ACID) SALTS OF 6-AMINOISOQUINOLINES AND USES THEREOF[2021/07]
French:SELS DE MONO-(ACIDE) DE 6-AMINOISOQUINOLINES ET LEURS UTILISATIONS[2021/07]
Entry into regional phase27.10.2020National basic fee paid 
27.10.2020Search fee paid 
27.10.2020Designation fee(s) paid 
27.10.2020Examination fee paid 
Examination procedure27.10.2020Examination requested  [2021/07]
16.08.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.10.2020Renewal fee patent year 03
25.03.2022Renewal fee patent year 04
27.02.2023Renewal fee patent year 05
26.02.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2010004239  (TANG PENG CHO [CN], et al) [Y] 2, 19/2, 35/2, 36/35/2, 37/36/35/2, 48/35/2, 49/2, 50/49/2, 51/49/2, 52/49/2, 53/52/49/2, 54/52/49/2, 55/2, 58/2, 59/58/2, 60/59/58/2, 61/2, 62/2 * ; paragraphs [0027], [0040], [0152] *;
 [XY]US2018050990  (STURDIVANT JILL M [US], et al) [X] 1, 4-8, 19-/1, 19/4-8, 35/1, 35/4-8, 36/35/1, 36/35/4-8, 37/36/35/1, 37/36/35/4-8 48/35/1, 48/35/4-8, 49/1, 49/4-8, 50/49/1, 50/49/4-8, 51/49/1, 51/49/4-8, 52/49/1, 52/49/4-8, 53/52/49/1, 53/52/49/4-8, 54/52/49/1, 54/52/49/4-8, 55/1, 55/4-8, 58/1, 58/4-8, 59/58/1, 59/58/4-8, 60/59/58/1, 60/59/58/4-8, 61/1, 61/4-8, 62/1, 62/4-8 * ; paragraphs [0008]-[0010], [0037], [0039], [0041], [0045], [0047], [0056], [0059], [0075], [0094], [0121], [0140], [0149] * [Y] 2, 19/2, 35/2, 36/35/2, 37/36/35/2, 48/35/2, 49/2, 50/49/2, 51/49/2, 52/49/2, 53/52/49/2, 54/52/49/2, 55/2, 58/2, 59/58/2, 60/59/58/2, 61/2, 62/2;
 [A]  - DONEGAN, RK et al., "Discovery of molecular therapeutics for glaucoma: Challenges, successes, and promising directions", Journal of Medicinal Chemistry, (20160211), vol. 59, no. 3, pages 788 - 809, XP055640474 [A] 1 * , re-numbered 1-44; page compound R-13 *

DOI:   http://dx.doi.org/10.1021/acs.jmedchem.5b00828
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.